(0.25%) 5 144.25 points
(0.20%) 38 516 points
(0.35%) 17 909 points
(-0.41%) $83.51
(1.98%) $1.961
(0.09%) $2 349.40
(0.52%) $27.68
(1.00%) $931.35
(-0.18%) $0.933
(-0.31%) $10.99
(-0.30%) $0.798
(1.14%) $92.92
1.69% $ 0.584
@ $0.897
Wydano: 14 vas. 2024 @ 22:28
Zwrot: -34.84%
Poprzedni sygnał: vas. 14 - 17:42
Poprzedni sygnał:
Zwrot: -0.39 %
Live Chart Being Loaded With Signals
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 176 491 |
Średni wolumen | 554 766 |
Kapitalizacja rynkowa | 4.28M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.0100 (1.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-02 | Gower Bob G | Buy | 90 287 | Common Stock |
2023-03-01 | Gower Bob G | Buy | 270 000 | Common Stock |
2023-02-28 | Gower Bob G | Buy | 109 300 | Common Stock |
2022-12-09 | Gower Bob G | Buy | 357 143 | Common Stock |
2022-12-09 | Gower Bob G | Buy | 714 286 | Warrants |
INSIDER POWER |
---|
99.26 |
Last 80 transactions |
Buy: 23 095 136 | Sell: 3 675 006 |
Wolumen Korelacja
Ensysce Biosciences, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SVAC | 0.928 |
PAIC | 0.905 |
PRVB | 0.904 |
SVOK | 0.878 |
ALR | 0.862 |
TLGT | 0.852 |
ALLR | 0.847 |
LKCO | 0.844 |
RDHL | 0.843 |
ELEV | 0.839 |
10 Najbardziej negatywne korelacje | |
---|---|
NETE | -0.92 |
LWAC | -0.92 |
MDRRP | -0.916 |
SRAC | -0.904 |
WSBCP | -0.895 |
RAVN | -0.889 |
HNST | -0.889 |
OVBC | -0.886 |
MRBK | -0.885 |
MNSBP | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ensysce Biosciences, Inc. Korelacja - Waluta/Towar
Ensysce Biosciences, Inc. Finanse
Annual | 2023 |
Przychody: | $2.23M |
Zysk brutto: | $-5.36M (-240.17 %) |
EPS: | $-4.69 |
FY | 2023 |
Przychody: | $2.23M |
Zysk brutto: | $-5.36M (-240.17 %) |
EPS: | $-4.69 |
FY | 2022 |
Przychody: | $2.52M |
Zysk brutto: | $-17.31M (-686.08 %) |
EPS: | $-138.73 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-29.60 |
Financial Reports:
No articles found.
Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej